{"identifier":"nobleid:/w1/20260526/9DAFAD76","arkIdentifier":"ark:/48914/w1/20260526/9DAFAD76","version":1,"workTitle":"Randomized, Open-label, Comparative Safety and Efficacy Study of Tipranavir Boosted With Low-dose Ritonavir (TPV/RTV) Verses Genotypically-defined Protease Inhibitor/Ritonavir (PI/RTV) in Multiple Antiretroviral Drug-experienced Patients.","workType":"Journal Article","authors":"Boehringer Ingelheim","description":null,"workUrl":null,"existingDoi":null,"createdAt":"2026-05-26T02:58:29.912074Z","canonicalUrl":"https://nobleid.org/ark:/48914/w1/20260526/9DAFAD76.v1"}